ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals Inc (AMLX)

13,32
-0,99
(-6,92%)
Geschlossen 07 Juni 10:00PM
13,29
-0,03
(-0,23%)
Nach Börsenschluss: 1:56AM

Amylyx Pharmaceuticals Inc (AMLX) Insidergeschäfte

-
Filtern nach:
Datum Name des Inhabers Gehandelte Aktien Wertspanne ($) Transaktionstyp Preisspanne ($) Aktien am Meldungsende % Veränderung
2026-05-21Ms. Karen Mindy FirestoneIndependent Director3,80k51,34kKauf13,5166,90k6,02%
2026-03-02Mr. James M. FratesCFO-7,91k114,85kVerkauf14,52210,02k-3,63%
2026-03-02Ms. Gina M. MazzarielloChief Legal Officer & General Counsel-6,84k99,38kVerkauf14,5259,04k-10,39%
2026-03-02Dr. Camille L. BedrosianChief Medical Officer-6,46k94,21kVerkauf14,5888,81k-6,78%
2026-03-02Mr. Joshua B. CohenCo-Founder, Co-CEO & Director-29,28k424,12kVerkauf14,483,11M-0,93%
2026-03-02Mr. Justin B. KleeCo-CEO & Director-29,28k423,76kVerkauf14,473,07M-0,95%
2026-02-23Ms. Gina M. MazzarielloChief Legal Officer & General Counsel-3,42k48,35kVerkauf14,1440,76k-7,74%
2026-02-02Mr. Justin B. KleeCo-CEO & Director-15,50k227,62kVerkauf14,693,10M-0,50%
2026-02-02Ms. Gina M. MazzarielloChief Legal Officer & General Counsel-3,45k50,52kVerkauf14,6543,09k-7,41%
2026-02-02Mr. Joshua B. CohenCo-Founder, Co-CEO & Director-15,50k227,59kVerkauf14,683,10M-0,50%
2026-02-02Mr. James M. FratesCFO-3,56k52,10kVerkauf14,65200,83k-1,74%
2026-01-15Mr. Justin B. KleeCo-CEO & Director61,81k467,92kDerivative Exercise and Retained Stock7,573,08M2,05%
2026-01-15Mr. Justin B. KleeCo-CEO & Director-138,19k831,49kDerivative Exercise and Sale7,57 - 13,893,08M-
2026-01-15Mr. Joshua B. CohenCo-Founder, Co-CEO & Director61,83k468,08kDerivative Exercise and Retained Stock7,573,08M2,05%
2026-01-15Mr. Joshua B. CohenCo-Founder, Co-CEO & Director-138,17k832,17kDerivative Exercise and Sale7,57 - 13,833,08M-
2026-01-12Dr. George Mclean MilneIndependent Chairman of the Board-17,78k0,00Other Disposition-812,88k-2,14%
2026-01-06Mr. Justin B. KleeCo-CEO & Director-7,72k85,59kVerkauf11,093,02M-0,26%
2026-01-06Mr. Joshua B. CohenCo-Founder, Co-CEO & Director-7,72k85,60kVerkauf11,093,02M-0,26%
2026-01-06Mr. James M. FratesCFO-3,33k36,95kVerkauf11,11194,38k-1,68%
2025-12-23Ms. Karen Mindy FirestoneIndependent Director8,10k100,85kKauf12,4563,10k14,73%
2025-12-01Dr. Camille L. BedrosianChief Medical Officer-6,58k94,42kVerkauf14,3578,17k-7,76%
2025-09-30Dr. Camille L. BedrosianChief Medical Officer-12,04k175,52kVerkauf14,5870,17k-14,65%
2025-09-30Ms. Gina M. MazzarielloChief Legal Officer & General Counsel-8,83k128,67kVerkauf14,5837,37k-19,11%
2025-09-30Mr. Joshua B. CohenCo-Founder, Co-CEO & Director-29,93k429,47kVerkauf14,34 - 15,003,01M-0,99%
2025-09-30Mr. James M. FratesCFO-10,56k154,65kVerkauf14,65189,79k-5,27%
2025-09-30Mr. Justin B. KleeCo-CEO & Director-29,98k430,95kVerkauf14,37 - 15,013,01M-0,99%
2025-08-12Ms. Gina M. MazzarielloChief Legal Officer & General Counsel-30,00k246,15kAutomatic Disposition8,07 - 8,3418,81k-61,46%